New daily pill could cut migraine days in half
NCT ID NCT06414044
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 500 Italian adults with migraine to see how well the daily pill atogepant works in everyday life. Researchers will measure changes in monthly migraine days over a year. The goal is to find out if atogepant is a safe and effective preventive treatment for people with episodic or chronic migraine.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atogepant
What this could lead to
If successful, this could show that atogepant is a safe and effective daily pill to prevent migraines in real-world patients.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It is also limited to Italian patients, so findings may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Campus Bio-Medico
Roma, 00128, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy